Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study.

MLA

Guillo, Lucas, et al. “Efficacy and Safety of Combination Targeted Therapies in Immune-Mediated Inflammatory Disease: The COMBIO Study.” Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol. 55, no. 1, Jan. 2023, pp. 61–68. EBSCOhost, https://doi.org/10.1016/j.dld.2022.07.012.

APA

Guillo, L., Flachaire, B., Avouac, J., Dong, C., Nachury, M., Bouguen, G., Buisson, A., Caillo, L., Fumery, M., Gilletta, C., Hébuterne, X., Lafforgue, P., Laharie, D., Mahé, E., Marotte, H., Nancey, S., Ottaviani, S., Salmon, J.-H., Savoye, G., … Pham, T. (2023). Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 55(1), 61–68. https://doi.org/10.1016/j.dld.2022.07.012

Chicago

Guillo, Lucas, Benoit Flachaire, Jérôme Avouac, Catherine Dong, Maria Nachury, Guillaume Bouguen, Anthony Buisson, et al. 2023. “Efficacy and Safety of Combination Targeted Therapies in Immune-Mediated Inflammatory Disease: The COMBIO Study.” Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 55 (1): 61–68. doi:10.1016/j.dld.2022.07.012.